Communication Overview
Communication is not only about showcasing our project but also about listening, learning, and co-creating. Throughout our journey, we actively engaged with universities, companies, hospitals, and academic conferences. These exchanges allowed us to gain valuable feedback on technical design, commercialization potential, and social impact, ensuring that our project stayed grounded in both scientific rigor and real-world needs.
University Interchange
As part of our communication efforts, we actively engaged with other university teams and research groups to broaden our perspectives and refine our project design. These exchanges provided us with opportunities not only to present our ideas, but also to learn from peers who are tackling challenges in synthetic biology with different approaches.
We structured our university exchanges into two levels:
Basic Exchange: Introductory meetings where we shared our project goals, listened to others' progress, and built mutual understanding. These sessions served as an important platform for networking and for gaining inspiration across diverse synthetic biology applications.
In-depth Exchange: More targeted discussions focused on project commercialization, inclusivity design, and technical validation. These conversations allowed us to critically examine our own strategies and receive constructive feedback from experienced student researchers and faculty advisors.
Through these dialogues, we developed a more comprehensive view of how synthetic biology projects can move beyond the lab—toward application, societal impact, and long-term sustainability.
Basic Exchange
To expand the visibility of our project and strengthen mutual understanding within the iGEM community, we engaged in basic exchanges with several universities, including Zhejiang University of Technology, the University of Science and Technology of China, and the University of Chinese Academy of Sciences.
During these interactions, we briefly introduced our project design and research goals, while also listening to the general directions of their projects. Although these exchanges did not involve in-depth discussions, they provided us with valuable opportunities to clearly present our ideas to peers from other institutions and to practice academic communication across teams.
These initial connections laid the groundwork for potential future collaborations and helped spread our project concepts among a broader academic audience. More importantly, they trained us in the skills of science communication and interdisciplinary dialogue—goals that lie at the heart of iGEM’s Communication track.
In-Depth Exchange
Wet Lab Advice
HP Advice
Model Advice
Comercialization Advice
Academic Conferences
Participating in academic conferences provided us with valuable opportunities to position our project within the broader scientific community. By attending high-level discussions and sharing our own work, we not only learned from cutting-edge advances in microbiology and synthetic biology but also tested the relevance and novelty of our project in front of experts and peers.
We took part in two major conferences:
CCiC 2025
The 2025 China iGEMer Community Conference (CCiC), themed Synbiopunk, combined the scientific rigor of synthetic biology with the rebellious spirit of punk. For our team, it was more than an academic gathering—it was a journey of inspiration and reflection.
Throughout the event, we witnessed how automation and artificial intelligence are reshaping the speed and accessibility of research. Danaher Life Sciences and Opentrons showcased high-throughput robotic platforms and AI-driven design tools, giving us new perspectives on how automated and intelligent workflows can accelerate experimentation. At the same time, scholars from Tsinghua University and Tianjin University hosted a special forum on “Biosafety and Responsibility,” highlighting governance challenges in gene editing and the potential risks of synthetic organisms. Their insights reminded us that innovation must go hand in hand with responsibility and ethics, a principle that has deeply influenced the safety measures we built into our own project.
Another striking feature of CCiC was the diversity of attendees. iGEM teams, startup founders, biotech investors, ethicists, and even artists all came together, creating a vibrant space where ideas crossed disciplinary boundaries. Discussions expanded beyond science into commercialization strategies and social impact, offering us valuable new perspectives for our project.
On August 7, we delivered a flash presentation of our work, focusing on the social burden of hyperuricemia, our engineered probiotic solution, and our biosafety considerations. During the Q&A session, we received direct feedback from professors, engineers, and peers on strain specificity, scalability, and the feasibility of future clinical translation. These exchanges not only helped us refine our design but also led to potential collaborations, broadening our academic and industrial connections.
For us, CCiC went far beyond information sharing. It illustrated both the present and the future of synthetic biology, emphasizing the power of cross-disciplinary integration and inclusivity, encouraging students to be contributors rather than mere learners, and demonstrating that the fusion of automation, artificial intelligence, and ethical responsibility will be key to advancing this field. CCiC was not just a platform for presentation—it was a call to action: to build projects that are not only scientifically sound but also socially responsible and globally relevant.
Bioreactor Engineering Conference
Unlike CCiC, which focused broadly on synthetic biology and its societal implications, the Bioreactor Engineering Conference emphasized the technological backbone required to transform laboratory-scale research into scalable applications. Cutting-edge talks on process intensification, continuous bioprocessing, and digital twin technologies showcased how modern bioreactors enable precise control of cell growth, metabolite production, and system safety. For our engineered probiotic strain, scalability and biocontainment are essential for future application. This conference exposed us to industrial strategies for safe scale-up and gave us new perspectives on how to align our design with manufacturing needs. While we remain in the research stage, these insights helped us imagine the translational pathway from bench to industry, reminding us that innovation must be paired with robust production processes to be impactful in real-world healthcare.
Conclusion
Through a series of multi-layered communication activities—including academic exchanges with universities, participation in international conferences, and dialogues with industry experts—we built a dynamic bridge between our project and the broader community. University exchanges provided us with peer feedback and fresh perspectives, helping us refine both our technical design and presentation skills. Meanwhile, CCiC and the Bioreactor Engineering Conference offered complementary insights: the former highlighted the societal responsibilities and ethical dimensions of synthetic biology, while the latter emphasized the technological foundations needed for safe scale-up and industrial translation.
Together, these efforts created a two-way process: while we shared the vision of engineered probiotics with diverse audiences, we also absorbed practical, real-world insights that shaped our project into a design that is scientifically rigorous, socially responsive, and industrially feasible. In this sense, communication was not an add-on, but a core driving force throughout our journey.
